Innovative

Immune Modulating

Therapies

iCell’s Novel Products Treat:

  • Systemic Lupus Erythematosus (Lupus)

  • Multiple Sclerosis (MS)

  • and other Chronic Autoimmune Conditions

  • T cell Malignancies

  • Acute Myeloid Leukemia (AML)

We research and develop chimeric antigen receptor engineered (CAR) cells to be first-in-class, cost effective, and life-saving.

Our Platforms :

  • Compound Cars (cCARs)

  • Non-Gene Editing CAR Technology for T-Cell Malignancies

  • Universal CARs

  • Super NK-cells

 

Our Core Pipeline

Our highly efficacious and safe constructs provide hope through providing desperately needed treatments for patients suffering from leukemias and lymphomas. We are approaching unmet clinical needs by the following timeline.